![Michael McNamara](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael McNamara
Keine laufenden Positionen mehr
Karriereverlauf von Michael McNamara
Ehemalige bekannte Positionen von Michael McNamara
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Altimmune UK Ltd.
![]() Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 05.10.1992 | 19.07.2003 |
Centrom Group Plc
![]() Centrom Group Plc Information Technology ServicesTechnology Services Centrom Group Plc provided computer system design services and software solutions to the healthcare sector. The company is headquartered in Newcastle upon Tyne, the United Kingdom. | Finanzdirektor/CFO | 01.01.2004 | - |
Statistik
International
Vereinigtes Königreich | 3 |
Operativ
Director/Board Member | 1 |
Director of Finance/CFO | 1 |
Sektoral
Technology Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Centrom Group Plc
![]() Centrom Group Plc Information Technology ServicesTechnology Services Centrom Group Plc provided computer system design services and software solutions to the healthcare sector. The company is headquartered in Newcastle upon Tyne, the United Kingdom. | Technology Services |
Altimmune UK Ltd.
![]() Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Michael McNamara
- Erfahrung